Clarendon Fund Managers

Clarendon Fund Managers is an active Belfast-based fund manager that backs scaling local life science companies across Northern Ireland. The firm operates as a regional fund manager with a focus on early-stage technology and life sciences founders, and is recognized as a meaningful early capital source within the Northern Ireland innovation ecosystem. Disclosed activity includes investments in companies such as LifeCellsNI, illustrating the firm’s appetite for science-based ventures emerging from regional research institutions and entrepreneurial founders. Within healthcare, the focus is on biotech and medical devices and medtech, with attention to companies that combine technical defensibility with credible commercial pathways. The team gravitates toward founders embedded in the Northern Ireland research and clinical ecosystem and values capital efficiency given the smaller round sizes typical of the region. Clarendon typically engages at pre-seed, seed, and Series A, with check sizes generally in the 250k to 1M range. The firm is comfortable leading or co-leading early rounds in Northern Ireland and joining syndicates with national and international co-investors when companies scale beyond initial regional financing. Geographic focus is Northern Ireland-led, with broader UK and Ireland deal flow considered selectively. Founders engaging Clarendon should expect a regionally informed diligence process, attention to capital efficiency and commercialization milestones appropriate to seed and Series A budgets, and post-investment support around regional networking, follow-on introductions to UK and Irish life sciences investors, and connections to clinical and academic resources. Limited public information is available regarding internal team composition and complete portfolio detail beyond disclosed investments.